ProjectMEDI 9929 in Adult Subjects with Moderate-to-Severe Atopic Dermatitis
Basic data
Title:
MEDI 9929 in Adult Subjects with Moderate-to-Severe Atopic Dermatitis
Duration:
30/09/2015 to 29/02/2016
Abstract / short description:
A Phase 2a Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Efficacy and Safety of MEDI9929 in Adult Subjects with Moderate-to-Severe Atopic Dermatitis
Keywords:
atopic dermatitis
Atopische Dermatitis
antibodies
Antikörper
Involved staff
Managers
Faculty of Medicine
University of Tübingen
University of Tübingen
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Contact persons
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Local organizational units
Department of Dermatology
Hospitals and clinical institutes
Faculty of Medicine
Faculty of Medicine
Funders
Cambridge, United Kingdom